Diverse participation in cancer clinical trials is key to ensuring new treatments are effective for all, NBCC’s Michelle Tregear writes in WebMD: “By addressing barriers and coming up with ways to increase diversity in clinical trial participation, we can ensure that new cancer treatments are safe, effective, and meaningful.”
Read the full article here.